DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

Anticoagulation Stewardship

Blood Global Hematology Editor-in-Chief Shares Vision

One on One With Dr. Fred Appelbaum

Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Growing the Next Generation of Hematologists

Women in Hematology

Four Is Better Than Three: Will We Finally Agree?

Toward Equity in Access for ALL

The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

Editors-in-Chief of Two New ASH Journals Share Their Visions

ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All

Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal

Drawing New Blood Into Hematology

Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action